Idex Corporation · NYSE:IEX

Idex — Q2 2014 Earnings Presentation

10 slides from Idex's earnings presentation, Jul 28, 2014

  1. Slide 1: Second Quarter Earnings

    Second Quarter Earnings JULY 23, 2014

  2. Slide 2: Agenda

    AGENDA IDEX Strategic Priorities Q2 2014 Financial Performance Q2 2014 Segment Performance • Fluid & Metering • Health & Science • Fire & Safety / Diversified Guidance Update Q&A 1

  3. Slide 3: Replay Information

    REPLAY INFORMATION Dial toll–free: 877.660.6853 International: 201.612.7415 Conference ID: #13583593 Log on to: www.idexcorp.com 2

  4. Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act

    Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward-looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause those

  5. Slide 5: IDEX Q2 Financial Performance

    Revenue Organic: 4% growth 130 bps expansion EPS Operating Margin Free Cash Flow Solid organic growth and margin expansion deliver 16 percent EPS growth 16% growth 22% decrease IDEX Q2 Financial Performance 4 $0 $200 $400 $600 Q2 $518 $547 2013 2014 $0.00 $0.50 $1.00 Q2 $0.76 $0.88 2013 2014 15.0% 2

  6. Slide 6: Fluid & Metering

    Orders Revenue Q2 Revenue Mix: Organic -2% Acquisition 1% Fx 1% Total 0% Q2 Summary:  Solid organic order growth has built a healthy backlog and positions us well going forward  Energy and Chemical markets have experienced demand volatility due to large project delays  Water Services continues to

  7. Slide 7: Health & Science

    Health & Science Orders Revenue Operating Margin Q2 Revenue Mix: Organic 1% Acquisition 0% Fx 2% Total 3% Q2 Summary:  IOP orders rebounded in the second quarter on the strength of the life sciences, industrial and semiconductor markets  MPT continues to see increased orders in Asia for industrial

  8. Slide 8: Fire & Safety / Diversified

    Orders Revenue 570 bps expansion Organic: 17% growth Operating Margin Q2 Revenue Mix: Organic 17% Acquisition 0% Fx 2% Total 19% Q2 Summary:  Across the segment, outstanding operating margin improvement is due to volume leverage, productivity and a prior year charge from a facility disposal  Dispe

  9. Slide 9: Outlook: 2014 Guidance Summary

    Q3 2014 EPS estimate range: $0.83 – $0.85 Operating margin: ~ 20% Tax rate: ~ 30% FY 2014 EPS estimate range: $3.50 – $3.55 Organic revenue growth: ~ 5% – 6% Operating margin: > 20% Minimal FX impact Other modeling items • Tax rate: ~ 29.0% – 29.5% • Cap Ex: ~ $45M – $50M • Free Cash Flow will be ~1

  10. Slide 10: Q&A

    Q&A 9

Idex — Q2 2014 Earnings Presentation on 6ix